HFrEF Flashcards
Etiologies of HFrEF
Loss of myocardium (MI, CAD)
Pressure overload (Chronic HTN, valvular dz)
Dilated cardiomyopathy (hyper metabolic, toxin exposure)
Myocarditis
HFrEF Epidemiology
HTN (women) and CAD (men)
45% of heart failure, not as many hospitalizations but worse prognosis
60% 5 year mortality rate
alterations in ventricular size and geometry causes secondary to:
valvular insufficiency (papillary muscle rearrangement)
subendocardial ischemia (decreased diastole = decreased coronary perfusion)
myocardial fibrosis (easier to develop arrhythmias)
cardiac renal anemia syndrome
decreased CO causes renal hypoperfusion
elevation in cytokine levels and bone marrow resistance to erythropoietin = anemia
increased plasma volume = worsening LV hypertrophy = cardiac dysfunction
myocardial stunning
ischemic events caused by prolonged systolic dysfunction
hours or days after event stops
myocardial hibernation
sustained reduction in blood flow = only enough to maintain viability but not enough to maintain normal contractility
myocyte apoptosis
combo of hibernation and stunning
progression of LV systolic dysfunction and reduced EF/CO
compensatory mechanisms heart uses (5)
- Frank Starling Law
- RAAS
- Norepinephrine
- ADH
- Vasodilator peptides/BNP
Frank Starling Law compensation in HF
excessive workload on heart causes normal cells to hypertrophy to increase contractile force
RAAS compensation in HF
afferent arterioles in kidneys respond to changes in arterial pressure via sympathetic release of renin to increase pressure
angiotensin II compensation in HF
myocyte hypertrophy, apoptosis, intercostal fibrosis, promotion of fibroblasts proliferation and collagen deposits
this is when RAAS compensation goes bad, results in stiffening of ventricles and arteries
norepinephrine compensation in HF
increases HR and contractility
eventually B-receptor density decreases so this compensation fails
ADH compensation in HF
simulated by norepinephrine and angiotensin II accumulation
increased water retention in kidney
BNP compensation in HF
vasodilator peptide
released by heart during HF to stimulate vasodilation and reduce pressures (RA, pulmonary a., pulmonary v.)
more common in rEF
release stimulates vascular resistance and CO, eventually overwhelmed by RAAS and norepinephrine
s/s of congestion
Pulmonary edema orthopnea PND hepatojugular reflex pulmonary rales and wheezing
s/s of impaired perfusion
fatigue/sleepiness cool extremities narrow pulse pressure low sodium increased CR
Left Sided HF symptoms
Fatigue mental status change narrow pulse pressure worsening renal function dyspnea pulmonary edema
R sided HF
JVD hepatomegaly anorexia weight gain ascites/anasarca/peripheral edema
cardinal symptoms
dyspnea and fatigue that occur with exertion and/or at rest
may see acute pulmonary edema
PND
supine position, causes choking and air hunger
must sit upright to regain control